Private equity firm Pharos Capital Group, LLC hired James S. Kerrigan and Kevin A. Ryan as senior financial analysts. Kerrigan will be based in Dallas and Ryan will work out of Nashville.
DALLAS and NASHVILLE – August 22, 2016–Pharos Capital Group, LLC, a private equity firm based in Dallas and Nashville, announced today it has hired James S. Kerrigan and Kevin A. Ryan as Senior Financial Analysts. Mr. Kerrigan will be based in Pharos’s Dallas office, while Mr. Ryan will be based in Nashville.
Prior to joining Pharos, Mr. Kerrigan spent two years as an Investment Banking Analyst at Barclays in New York, advising on deals in the healthcare, packaging, chemicals and strategic finances sectors. Before that, he worked in various capacities at a private equity family office and a healthcare consulting firm in Nebraska. He holds a BA in Accounting, Finance, Banking & Investment Science from the University of Nebraska at Omaha.
Mr. Ryan worked for two years as an Investment Banking Analyst for Stephens Inc. in Little Rock, AR before joining Pharos. He advised on M&A and private equity transactions across multiple industries, including healthcare services. Mr. Ryan has a BS in Business Administration from the University of Tennessee.
“We are excited to welcome Jim and Kevin, who are already fully engaged as we just closed on the purchase of telepsychiatry services provider FasPsych, LLC and are busy with a full pipeline,” said Kneeland Youngblood, co-founder and Managing Partner of Pharos Capital. “Both bring strong backgrounds in a variety of industries and we look forward to their contributions to the firm as Pharos continues to deploy the capital from our latest fund.”
About Pharos Capital Group
Based in Dallas and Nashville, Pharos Capital Group is an SEC Registered Investment Advisor. Since inception, Pharos has invested in 49 companies and currently has approximately $800 million of private equity assets under management. Pharos typically invests $25-$50 million in rapidly growing middle market companies seeking later stage funding for internal growth, acquisitions, leveraged buyouts, management buyouts, or recapitalizations predominantly across healthcare sectors. For more information about Pharos, please visit www.pharosfunds.com.